Arbutus Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV).
ABUS Key Statistics
Stock Snapshot
As of today, Arbutus Biopharma(ABUS) shares are valued at $4.43. The company's market cap stands at 873.44M, with a P/E ratio of -25.09.
During the trading session on 2026-05-06, Arbutus Biopharma(ABUS) shares reached a daily high of $4.48 and a low of $4.42. At a current price of $4.43, the stock is +0.2% higher than the low and still -1.2% under the high.
Trading volume for Arbutus Biopharma(ABUS) stock has reached 174.3K, versus its average volume of 2.46M.
The stock's 52-week range extends from a low of $2.94 to a high of $5.10.
The stock's 52-week range extends from a low of $2.94 to a high of $5.10.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.